GRAFT FAILURE
Clinical trials for GRAFT FAILURE explained in plain language.
Never miss a new study
Get alerted when new GRAFT FAILURE trials appear
Sign up with your email to follow new studies for GRAFT FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
One-Dose drug may clear path to second kidney transplant
Disease control CompletedThis study tested whether a single dose of tocilizumab, given right before or after removing a failed kidney transplant, can safely lower the immune system's production of antibodies that make a second transplant difficult. 18 adults who needed their graft removed and hoped for a…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: University Hospital, Toulouse • Aim: Disease control
Last updated May 17, 2026 03:13 UTC
-
New Blood-Cleansing method boosts transplant success in sensitized patients
Disease control CompletedThis study looked at 50 patients who needed a stem cell transplant from a partially matched donor but had antibodies that could attack the donor cells. Before transplant, they received a blood purification treatment called protein A immunoadsorption to remove those antibodies. Th…
Matched conditions: GRAFT FAILURE
Sponsor: Ting YANG • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
Could a Once-Daily pill prevent heart transplant rejection just as well?
Disease control CompletedThis study tested whether a once-daily anti-rejection medication (Envarsus) works as well as the standard twice-daily drug (Prograf) in heart transplant patients. Fifty adults who received a heart transplant took part. The goal was to see if the easier once-daily dosing could hel…
Matched conditions: GRAFT FAILURE
Phase: PHASE2 • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC